Incidence and clinical significance of therapy-induced neutralizing antibodies against interferon-beta.
Fierlbeck
G
G
Department of Dermatology, University of Tübingen, Germany.
Schreiner
T
T
D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D005500:Follow-Up Studies; D006801:Humans; D007370:Interferon Type I / Q000276:immunology / Q000627:therapeutic use*; D016899:Interferon-beta / Q000276:immunology / Q000627:therapeutic use*; D008545:Melanoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D011994:Recombinant Proteins; D017186:Titrimetry
D007370:Interferon Type I; D011994:Recombinant Proteins; D016899:Interferon-beta